Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Keith McCarthy"'
Autor:
Mahdi Nohtani, Katerina Vrzalikova, Maha Ibrahim, Judith E. Powell, Éanna Fennell, Susan Morgan, Richard Grundy, Keith McCarthy, Sarah Dewberry, Jan Bouchal, Katerina Bouchalova, Pamela Kearns, Paul G. Murray
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4297
In this study, we have re-evaluated how EBV status influences clinical outcome. To accomplish this, we performed a literature review of all studies that have reported the effect of EBV status on patient outcome and also explored the effect of EBV pos
Autor:
Mary, Gerrard, Ian M, Waxman, Richard, Sposto, Anne, Auperin, Sherrie L, Perkins, Stanton, Goldman, Lauren, Harrison, Ross, Pinkerton, Keith, McCarthy, Martine, Raphael, Catherine, Patte, Mitchell S, Cairo
Publikováno v:
Blood. 121:278-285
Mediastinal large B-cell lymphoma (MLBL) represents 2% of mature B-cell non-Hodgkin lymphoma in patients ≤ 18 years of age. We analyzed data from childhood and adolescent patients with stage III MLBL (n = 42) and non-MLBL DLBCL (n = 69) treated wit
Publikováno v:
IEEE Transactions on Industry Applications. 48:1717-1730
This paper shares the authors' experiences with implementing an electrical network monitoring and control system (ENMCS) on a grassroots 400 000 barrels per day refinery project with approximately 250 MW of peak load. The scope of the ENMCS spans fro
Autor:
Mary Gerrard, A. Auperin, Keith McCarthy, Ross Pinkerton, Richard Sposto, Mitchell S. Cairo, Catherine Patte, Sherrie L. Perkins, Martine Raphael, Lauren Harrison, Stanton Goldman
Publikováno v:
Journal of Clinical Oncology. 30:387-393
Purpose Adolescents (age 15 to 21 years) compared with younger children with mature B-cell non-Hodgkin's lymphoma (NHL) have been historically considered to have an inferior prognosis. We therefore analyzed the impact of age and other diagnostic fact
Autor:
Keith McCarthy, Maria Visaduraki, Martin Hewitt, Ananth Shankar, Bruce Morland, Janis Hayward
Publikováno v:
European Journal of Cancer. 48:108-113
Purpose To assess the efficacy of a standardised hybrid chemotherapy treatment programme for Hodgkin lymphoma (HL) in a national series of children and adolescents. Patients and methods The 381 assessable patients, treated between March 2000 and Apri
Autor:
Laurence Lamant, Laurence Brugières, Georges Delsol, Marie-Cécile Le Deley, Maximo Fraga, Atsuko Nakagawa, Ilske Oschlies, Emanuele S.G. d'Amore, Jadwiga Maldyk, Ingrid Simonitsch-Klupp, Keith McCarthy, Wolfram Klapper, Audrey Mauguen
Publikováno v:
Journal of Clinical Oncology. 29:4669-4676
Purpose The prognostic value of pathologic characteristics of childhood ALK-positive anaplastic large-cell lymphomas (ALCL), such as histologic subtypes, immunophenotype, and presence of the t(2;5) translocation or its variants, was assessed. Patient
Autor:
Keith McCarthy, Mark A. Lones, Catherine Patte, Rodney R. Miles, Andrew Wotherspoon, Mitchell S. Cairo, Mary Gerrard, Marie José Terrier-Lacombe, Richard Sposto, Sherrie L. Perkins, Martine Raphael, Anne Auperin, Virginia Davenport
Publikováno v:
Pediatric Blood & Cancer. 51:369-374
Background Diffuse large B-cell lymphoma (DLBCL) makes up 10–20% of pediatric non-Hodgkin lymphoma, and these patients have a significantly better prognosis than adults with DLBCL. The difference in prognosis may be related to clinical, phenotypic,
Autor:
Ilske Oschlies, Martin Zimmermann, Laurence Brugières, Alfred Reiter, Denise Williams, Marie-Cécile Le Deley, Keith McCarthy, Georges Delsol
Publikováno v:
Blood. 111:1560-1566
To study prognostic factors of progression/relapse, data concerning 225 children enrolled between 1987 and 1997 in Berlin-Frankfurt-Münster, Société Française d'Oncologie Pédiatrique and United Kingdom Children's Cancer Study Group prospective s
Autor:
C. Ross Pinkerton, Claire Weston, Jean Michon, Richard Sposto, Martine Raphael, Anne Auperin, Mary Gerrard, Catherine Patte, Sherrie L. Perkins, Keith McCarthy, Mitchell S. Cairo
Publikováno v:
Blood. 109:2736-2743
The prognosis for higher risk childhood B-cell non-Hodgkin lymphoma has improved over the past 20 years but the optimal intensity of treatment has yet to be determined. Children 21 years old or younger with newly diagnosed B-cell non-Hodgkin lymphoma
Autor:
Ross Pinkerton, Jean Michon, Mary Gerrard, Sherrie L. Perkins, Richard Sposto, Martine Raphael, Claire Weston, Anne Auperin, Mitchell S. Cairo, Catherine Patte, Keith McCarthy
Publikováno v:
Blood. 109:2773-2780
A previous study (LMB89) of the French Society of Pediatric Oncology for childhood mature B-cell lymphoma (B-NHL) demonstrated a 92% 3-year event-free survival (EFS) for intermediate-risk group B defined as “non-resected” stage I/II and CNS-negat